-
Income Statement
-
Balance Sheet
-
Cashflow Statement
-
Profitability
-
Ratios
Cardinal Health Income Statement
Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|
Revenue |
|
$152.92 B | $162.47 B | $181.36 B | $205.01 B | $226.83 B |
Cost of Revenue |
|
$146.05 B | $155.69 B | $174.82 B | $198.12 B | $219.41 B |
Gross Profit |
|
$6.87 B | $6.78 B | $6.55 B | $6.89 B | $7.41 B |
Research & Development |
|
- | - | - | - | - |
Selling,General & Administrative |
|
$4.57 B | $4.53 B | $4.56 B | $4.83 B | $5.00 B |
Operating Expense |
|
$5.10 B | $4.98 B | $4.88 B | $5.12 B | $6.14 B |
Operating Income |
|
$1.77 B | $1.84 B | $1.65 B | $727.00 M | $1.24 B |
Net Income |
|
-$3.69 B | $611.00 M | -$932.00 M | $261.00 M | $852.00 M |
Cardinal Health Balance Sheet
Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|
Cash and Cash Equivalents |
|
$2.77 B | $3.41 B | $4.72 B | $4.04 B | $5.13 B |
Inventories |
|
$13.20 B | $14.59 B | $15.64 B | $15.94 B | $14.96 B |
Total Current Assets |
|
$25.94 B | $31.05 B | $32.94 B | $33.83 B | $34.88 B |
Property,Plant and Equipment |
|
$2.37 B | $2.36 B | $2.36 B | $2.46 B | $3.00 B |
Goodwill |
|
$8.36 B | $7.99 B | $5.86 B | $4.61 B | $4.73 B |
Total Assets |
|
$40.77 B | $44.45 B | $43.88 B | $43.42 B | $45.12 B |
Total Liabilities |
|
$38.97 B | $42.66 B | $44.58 B | $46.27 B | $48.33 B |
Retained Earnings |
|
$1.17 B | $1.21 B | -$280.00 M | -$534.00 M | -$286.00 M |
Total Shareholder Equity |
|
$1.79 B | $1.79 B | -$706.00 M | -$2.85 B | -$3.21 B |
Common Stock |
|
$2.79 B | $2.81 B | $2.81 B | $2.75 B | $2.92 B |
Cardinal Health Cash flow
Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|
Depreciation & Amortization |
|
$913.00 M | $783.00 M | $692.00 M | $692.00 M | $710.00 M |
Dividends Payout |
|
-$569.00 M | -$573.00 M | -$559.00 M | -$525.00 M | -$499.00 M |
Capital Expenditures (Capex) |
|
-$375.00 M | -$400.00 M | -$387.00 M | -$481.00 M | -$511.00 M |
Free Cash Flow (FCF) |
|
$1.59 B | $2.03 B | $2.74 B | $2.36 B | $3.25 B |
Cardinal Health Profitability
Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|
Gross Profit |
|
$6.87 B | $6.78 B | $6.55 B | $6.89 B | $7.41 B |
Gross Profit Margin (%) |
|
4.49% | 4.17% | 3.61% | 3.36% | 3.27% |
Operating Income |
|
$1.77 B | $1.84 B | $1.65 B | $727.00 M | $1.24 B |
Operating Income Margin (%) |
|
1.16% | 1.13% | 0.91% | 0.35% | 0.55% |
Net Income |
|
-$3.69 B | $611.00 M | -$932.00 M | $261.00 M | $852.00 M |
Net Income Margin (%) |
|
-2.41% | 0.38% | -0.51% | 0.13% | 0.38% |
EBITDA |
|
-$2.62 B | $1.31 B | $126.00 M | $1.44 B | $1.98 B |
EBITDA Margin (%) |
|
-1.71% | 0.81% | 0.07% | 0.70% | 0.87% |
Cardinal Health Ratios
Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|
Return on Equity (ROE) |
|
-206.08% | 34.06% | 132.01% | -9.15% | -26.52% |
Return on Assets (ROA) |
|
-9.06% | 1.37% | -2.12% | 0.60% | 1.89% |
Debt to Equity |
|
378.07% | 347.60% | -752.83% | -164.89% | -158.48% |
Debt to total asset |
|
16.62% | 14.03% | 12.11% | 10.83% | 11.29% |
Enterprise value to revenue |
|
0.13 | 0.12 | 0.08 | 0.12 | 0.11 |
Enterprise value to EBITDA |
|
-7.37 | 14.88 | 120.49 | 17.59 | 12.09 |
Enterprise value |
|
$19.30 B | $19.50 B | $15.18 B | $25.34 B | $23.91 B |
Cash to Debt |
|
28.93% | 38.95% | 58.74% | 60.39% | 73.88% |
Tax Rate (%) |
|
2.09% | -89.47% | -21.20% | 58.93% | 28.98% |
Payout Ratio |
|
-15.41% | 93.78% | -59.98% | 201.15% | 58.57% |